AbstractGet full access to this articleView all access options for this article.Get accessReferences1. Wolff HB , Steeghs EMP , Mfumbilwa ZA , et al. Cost-Effectiveness of Parallel Versus Sequential Testing of Genetic Aberrations for Stage IV Non-Small-Cell Lung Cancer in the Netherlands. JCO Precis Oncol. , 2022; 6: e2200201. doi: 10.1200/PO.22.00201.